Hinge Health Inc. (NYSE:HNGE - Get Free Report) shot up 4.3% on Monday. The stock traded as high as $118.50 and last traded at $120.3760. Approximately 87,959 shares changed hands during mid-day trading, a decline of 95% from the average session volume of 1,629,886 shares. The stock had previously closed at $115.39.
Analyst Upgrades and Downgrades
HNGE has been the topic of a number of recent analyst reports. Citizens Jmp lifted their price objective on Hinge Health from $96.00 to $107.00 and gave the stock a "market outperform" rating in a research report on Wednesday, August 5th. Bank of America initiated coverage on Hinge Health in a report on Tuesday, September 29th. They set a "buy" rating and a $110.00 target price for the company. Weiss Ratings raised Hinge Health from a "hold (c-)" rating to a "hold (c)" rating in a research note on Tuesday, November 10th. Needham & Company LLC lifted their price target on shares of Hinge Health from $115.00 to $135.00 and gave the company a "buy" rating in a report on Tuesday, November 3rd. Finally, Robert W. Baird boosted their price objective on shares of Hinge Health from $85.00 to $90.00 and gave the company a "neutral" rating in a research report on Tuesday, September 22nd. Two research analysts have rated the stock with a Strong Buy rating, fifteen have issued a Buy rating and two have given a Hold rating to the company's stock. Based on data from MarketBeat, the stock has a consensus rating of "Buy" and a consensus target price of $118.93.
Get Our Latest Report on Hinge Health
Hinge Health Stock Performance
The company has a market cap of $9.86 billion, a P/E ratio of 61.73, a price-to-earnings-growth ratio of 1.63 and a beta of 1.19. The stock has a 50-day moving average of $103.82 and a two-hundred day moving average of $70.81.
Hinge Health (NYSE:HNGE - Get Free Report) last announced its quarterly earnings results on Monday, November 2nd. The company reported $0.71 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.27 by $0.44. Hinge Health had a net margin of 21.02% and a return on equity of 66.96%. The company had revenue of $234.97 million for the quarter. During the same quarter in the previous year, the firm earned ($0.02) EPS. The business's revenue for the quarter was up 52.4% on a year-over-year basis. Research analysts predict that Hinge Health Inc. will post 1.56 EPS for the current year.
Insiders Place Their Bets
In other Hinge Health news, President James Pursley sold 33,000 shares of the business's stock in a transaction dated Monday, September 21st. The stock was sold at an average price of $94.14, for a total value of $3,106,620.00. Following the completion of the transaction, the president owned 666,909 shares of the company's stock, valued at approximately $62,782,813.26. The trade was a 4.71% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CFO James Budge sold 35,907 shares of the company's stock in a transaction dated Tuesday, November 10th. The shares were sold at an average price of $121.62, for a total transaction of $4,367,009.34. Following the transaction, the chief financial officer owned 256,207 shares in the company, valued at $31,159,895.34. This represents a 12.29% decrease in their position. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Over the last three months, insiders sold 1,260,488 shares of company stock valued at $124,481,770. 18.92% of the stock is currently owned by corporate insiders.
Institutional Inflows and Outflows
A number of hedge funds and other institutional investors have recently added to or reduced their stakes in the stock. Steward Partners Investment Advisory LLC purchased a new stake in Hinge Health during the 3rd quarter valued at $26,000. IFP Advisors Inc grew its stake in shares of Hinge Health by 140.0% during the 2nd quarter. IFP Advisors Inc now owns 324 shares of the company's stock valued at $27,000 after purchasing an additional 189 shares during the period. Global Retirement Partners LLC grew its stake in shares of Hinge Health by 9,400.0% during the 3rd quarter. Global Retirement Partners LLC now owns 285 shares of the company's stock valued at $28,000 after purchasing an additional 282 shares during the period. Nykredit A S bought a new stake in shares of Hinge Health during the 2nd quarter valued at about $29,000. Finally, SBI Securities Co. Ltd. increased its position in shares of Hinge Health by 39.5% during the 3rd quarter. SBI Securities Co. Ltd. now owns 364 shares of the company's stock valued at $35,000 after purchasing an additional 103 shares during the last quarter.
About Hinge Health
(
Get Free Report)
Hinge Health is a digital health company focused on musculoskeletal care, including support for people with back, joint and muscle pain. Its services are designed to help members manage conditions through personalized, technology-enabled care. The company's offerings include app-based exercise therapy, education and behavioral support, along with access to clinical care teams. Hinge Health also uses wearable motion sensors in some programs to guide and track exercises. Founded in 2015, Hinge Health primarily provides its services through employers and health plans.
Further Reading
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Hinge Health, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Hinge Health wasn't on the list.
While Hinge Health currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
The AI wave will soon hit public markets with Anthropic and OpenAI set to go public later this year. However, you don't have to wait to invest. This report shows seven AI stocks that you can buy today while the big model providers get ready to go public.
Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Like this article? Share it with a colleague.
Link copied to clipboard.